Detalhe da pesquisa
1.
Activation of the dopamine 1 and dopamine 5 receptors increase skeletal muscle mass and force production under non-atrophying and atrophying conditions.
BMC Musculoskelet Disord
; 12: 27, 2011 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-21269506
2.
Treatment with a corticotrophin releasing factor 2 receptor agonist modulates skeletal muscle mass and force production in aged and chronically ill animals.
BMC Musculoskelet Disord
; 12: 15, 2011 Jan 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-21235761
3.
Corticortophin releasing factor 2 receptor agonist treatment significantly slows disease progression in mdx mice.
BMC Med
; 5: 18, 2007 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-17626629
4.
Modifications of the human urocortin 2 peptide that improve pharmacological properties.
Peptides
; 27(7): 1806-13, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16476507